Adequan for Dogs, Cats, and Horses

By Dr Duncan Houston

Adequan is one of the better-known injectable joint therapies in veterinary medicine because it is not just being used to mask pain. It is used to support joint health more directly, particularly in dogs and horses with osteoarthritis or degenerative joint disease. In dogs, Adequan Canine is FDA-approved for intramuscular use in non-infectious degenerative or traumatic arthritis of synovial joints, while in horses Adequan i.m. is approved for degenerative or traumatic joint dysfunction and associated lameness of the carpal and hock joints. (Adequan Canine)

In practice, Adequan is often part of a bigger arthritis plan rather than a magic solo fix. It can be useful because it aims to support cartilage and joint fluid, but it still works best alongside weight control, appropriate exercise, rehab, and sensible pain management. Merck describes polysulfated glycosaminoglycan as a chondroprotective agent, and notes it may be more beneficial earlier in osteoarthritis, especially in dogs. (Merck Veterinary Manual)

Quick Answer

Adequan is an injectable polysulfated glycosaminoglycan used mainly for osteoarthritis and degenerative joint disease in dogs and horses, and it is sometimes used off-label in cats. It is considered a disease-modifying joint therapy rather than simple pain relief, because it may help protect cartilage, support joint fluid, and reduce harmful joint processes. It is generally well tolerated, but caution is needed in pets with bleeding disorders, in breeding or pregnant animals where safety has not been fully established, and in cases where the real cause of lameness has not been properly identified. (Adequan Canine)

What Is Adequan?

Adequan contains polysulfated glycosaminoglycan, often shortened to PSGAG. It is a semisynthetic glycosaminoglycan derived from bovine tracheal cartilage, and the main glycosaminoglycan in the product is chondroitin sulfate. (Adequan Canine)

That matters because glycosaminoglycans are part of normal cartilage structure. They help cartilage hold water and deal with compression, which is one reason they are relevant in arthritic joints. But Adequan is not just supplying building material. Merck and the manufacturer both describe actions that include inhibiting destructive enzymes, supporting synovial fluid, and helping cartilage metabolism. (Merck Veterinary Manual)

What Is Adequan Used For?

In dogs

Adequan Canine is approved for the intramuscular treatment of non-infectious degenerative or traumatic arthritis of synovial joints. In practical terms, that usually means osteoarthritis and chronic joint disease. (Adequan Canine)

In horses

Adequan i.m. is approved for intramuscular treatment of non-infectious degenerative or traumatic joint dysfunction and associated lameness of the carpal and hock joints. (DailyMed)

In cats

Use in cats is off-label. Merck notes a dosing approach used in cats with osteoarthritis, but this is not the same as labeled approval. That distinction matters. Off-label use is common in veterinary medicine, but it should not be presented as the same as formal approval. (Merck Veterinary Manual)

How Does Adequan Work?

Adequan is considered a chondroprotective or disease-modifying osteoarthritis therapy. It is used because it may help:

• reduce inflammatory processes within the joint

• inhibit enzymes that damage cartilage and synovial fluid

• support synovial lubrication

• support cartilage repair or maintenance processes (Merck Veterinary Manual)

This is why it gets positioned differently from NSAIDs. NSAIDs mainly reduce pain and inflammation. Adequan is used in an attempt to influence the joint environment itself. That does not make it a replacement for pain control in every patient, but it is one reason it can be valuable earlier in the disease process. (Merck Veterinary Manual)

How Is Adequan Given?

In dogs, the labeled Adequan Canine dose is 2 mg/lb body weight by intramuscular injection only, typically twice weekly for up to 4 weeks for a total of 8 injections. (Adequan Canine)

In horses, the labeled Adequan i.m. dose is 500 mg intramuscularly every 4 days for 28 days. (DailyMed)

Merck also notes that in dogs, polysulfated glycosaminoglycan may be given at 4.4 mg/kg IM or SC twice weekly for up to 8 treatments, and in cats describes an off-label protocol that starts twice weekly and tapers over time. (Merck Veterinary Manual)

The practical point is simple: this is an injection-based therapy, and the schedule matters. It is not the sort of medication where random timing is likely to give the best result.

What Benefits Should You Expect?

The main goals are:

• better comfort

• improved mobility

• reduced lameness

• improved joint lubrication

• potentially less reliance on other medications in some patients (Adequan)

In practice, the dogs and horses that seem to benefit most are often the ones with early to moderate osteoarthritis, where there is still room to protect joint function before more irreversible damage builds up. Merck specifically notes that PSGAG may be more beneficial in earlier stages of osteoarthritis. (Merck Veterinary Manual)

What matters most is realistic expectations. Adequan is not usually a same-day miracle. It is more of a joint-support strategy than a dramatic instant pain switch.

What Side Effects Can Occur?

Adequan is generally considered well tolerated, but side effects can happen. The dog label reports mild injection site pain, transient pain, swelling or increased lameness, vomiting, diarrhea, depression, and abnormal bleeding among possible adverse effects, although many are uncommon. Clinical trial information also noted diarrhea in some treated dogs. (Adequan Canine)

Because PSGAG has some chemical similarity to heparin, caution is advised in animals with clotting or bleeding problems. Merck also notes that intra-articular use in horses should be avoided where septic arthritis is a concern, and labeled information for horses emphasizes proper injection technique and cautions related to bleeding and contamination. (Merck Veterinary Manual)

The real-world takeaway is this: most pets tolerate it well, but if a patient already has a bleeding disorder, unexplained bruising, or concurrent drugs affecting clotting, you need to think more carefully.

How Worried Should You Be? Severity Framework

Mild

• mild soreness at the injection site

• mild soft stool

• temporary reluctance to move after the injection

This is often manageable and short-lived.

Moderate

• repeated diarrhea

• noticeable worsening of lameness

• appetite drop

• bruising or unusual sensitivity after injection

This should prompt a review with your veterinarian.

Severe

• significant bleeding

• collapse

• marked swelling or severe pain after injection

• rapid worsening of lameness that suggests something else is going on

This needs prompt veterinary attention.

A useful decision checkpoint is this: mild post-injection discomfort is one thing. A pet that seems dramatically worse, weak, or unexpectedly bruised deserves proper reassessment.

Which Pets Need Extra Caution?

Caution is sensible in:

• animals with known bleeding disorders

• pets on anticoagulants or antiplatelet drugs

• animals with significant kidney disease

• pregnant or lactating animals, because safety has not been fully established

• breeding animals where formal safety studies are limited (Adequan Canine)

That does not mean Adequan is automatically unsafe in every complicated case. It means it should not be treated like a casual supplement. It is still a prescription injectable drug.

Drug Interactions That Matter

There are no major routine interaction warnings like you would see with some heart or seizure drugs, and Adequan is commonly used alongside NSAIDs, rehabilitation therapy, omega-3 fatty acids, and weight management programs in arthritis patients. However, because of its anticoagulant-like properties, more caution is sensible in animals on drugs that affect clotting or platelet function. (Adequan Canine)

That is the practical issue here. The concern is less about dramatic classic drug interactions and more about stacking bleeding risk in the wrong patient.

What Could Look Like an Adequan Failure but Be Something Else?

Not every limping dog or stiff cat has straightforward osteoarthritis.

Important rule-outs include:

• cruciate disease

• hip instability

• neurological disease

• immune-mediated joint disease

• septic arthritis

• bone cancer

• soft tissue injury

• obesity-driven discomfort without a clear joint diagnosis

This matters because Adequan is most helpful when the problem really is degenerative joint disease. If the diagnosis is wrong, the treatment will look disappointing even if the drug itself is fine.

When Is This an Emergency?

Seek veterinary attention more urgently if:

• your pet suddenly cannot bear weight

• there is severe swelling after injection

• you notice bleeding, bruising, or collapse

• the lameness is rapidly worsening

• your pet seems unwell overall, not just stiff

Arthritis is usually chronic and gradual. Sudden severe deterioration should make you think beyond ordinary osteoarthritis.

What Should You Do Next?

If your pet has just started Adequan

• make sure the diagnosis makes sense

• follow the injection schedule closely

• ask how improvement will be judged

• keep a simple mobility diary so you can track real change

If your pet is improving

• keep the plan consistent

• combine the injections with weight control, sensible exercise, and home adjustments if needed

• review whether other pain medications still need to stay the same

If your pet is not improving

• do not just keep repeating injections blindly

• review whether the diagnosis is correct

• consider whether pain control, rehab, or imaging needs to change

If your cat is using it off-label

• make sure expectations are clear

• remember that evidence and protocols are less standardized than in dogs

Common Mistakes Owners Make

1. Expecting it to act like a same-day painkiller

It usually does not.

2. Using it without a solid diagnosis

Joint pain is not always just arthritis.

3. Ignoring body weight and lifestyle

No injectable therapy can outwork chronic overloading of bad joints.

4. Treating it like a supplement instead of a real prescription drug

Adequan is generally safe, but it still deserves proper monitoring and judgment.

5. Assuming off-label feline use is identical to labeled canine use

It is not.

Can Adequan Prevent Future Joint Problems?

It is more accurate to say it may help slow progression and support joint function rather than prevent arthritis entirely. Merck and product materials describe disease-modifying and cartilage-protective effects, especially when used earlier in the disease process. (Merck Veterinary Manual)

That is why I tend to view it as part of a proactive arthritis strategy, not just a rescue plan once a dog is already very sore.

Will My Pet Be Okay?

Many dogs and horses do well on Adequan when it is used for the right reason. It is generally well tolerated, and for some patients it becomes a useful part of long-term mobility care. Cats may also benefit in selected off-label cases, but expectations should be more cautious because the evidence base and protocols are less standardized. (Merck Veterinary Manual)

The bigger lesson is that Adequan works best when it is part of a full plan. If you ignore weight, exercise, flooring, rehab, and pain reassessment, you are asking one injection to do too much heavy lifting.

FAQs

What is Adequan used for in dogs?

Adequan Canine is FDA-approved for intramuscular treatment of non-infectious degenerative or traumatic arthritis of synovial joints in dogs. (Adequan Canine)

Is Adequan just a pain reliever?

No. It is considered a disease-modifying or chondroprotective therapy, which is different from simple pain masking. (Merck Veterinary Manual)

How is Adequan given to dogs?

The labeled canine protocol is 2 mg/lb IM twice weekly for up to 4 weeks, for a total of 8 injections. (Adequan Canine)

Can cats get Adequan?

Yes, vets sometimes use PSGAG off-label in cats, but this is not the same as labeled approval. (Merck Veterinary Manual)

Is Adequan safe with NSAIDs?

It is commonly used alongside broader arthritis plans that may include NSAIDs, but each patient still needs individual review. (Merck Veterinary Manual)

What side effects are most common?

Most reported effects are mild, such as injection site discomfort or gastrointestinal upset, but bleeding concerns matter more in at-risk patients. (Adequan Canine)

How quickly does Adequan work?

It is not usually an instant pain reliever. Improvement is often judged over the course of the injection series rather than after one dose. This is an inference based on the standard treatment schedule and how the drug is used clinically. (Adequan Canine)

Can Adequan be used in horses?

Yes. Adequan i.m. is approved in horses for degenerative or traumatic joint dysfunction and associated lameness of the carpal and hock joints. (DailyMed)

Final Thoughts

Adequan is one of the more useful joint-support medications we have because it aims at the disease process, not just the pain signal. That makes it particularly appealing in earlier arthritis cases or in patients where you want a broader, more proactive mobility plan. (Merck Veterinary Manual)

The main practical takeaway is this: Adequan can help, but it works best when it is used for the right diagnosis and combined with everything else that protects joints over time. If your pet is still deteriorating, suddenly much worse, or not improving at all, the answer is not always “more Adequan.” Sometimes the diagnosis or the wider plan needs to change.

If you need help deciding whether Adequan fits your pet’s arthritis plan, whether the response is what you should expect, or whether a worsening limp needs a different workup, ASK A VET™ can help you work through that more clearly.